Jean-Luc Raoul

Prof

Institut de Cancérologie de l'Ouest

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Jean-Luc Raoul is affiliated with the Institut de cancérologie de l'Ouest in Saint Herblain, France. His current research areas include the management of gastrointestinal tract cancers, the impact of COVID-19 on cancer patients, and drug interactions affecting cancer therapies. He has contributed to a number of significant studies in these fields, including trials on peritoneal metastases and the effects of proton pump inhibitors in oncology.

Articles (13)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Aurélien Lambert

FRANCE

View details

Tim Meyer

University College London

UNITED KINGDOM

View details

Come Lepage

Université de Bourgogne

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jean-Luc Raoul

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial

How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology

Drug–drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure

COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19)

COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19)

COVID-19 Infections in Cancer Patients Were Frequently Asymptomatic: Description From a French Prospective Multicenter Cohort (PAPESCO-19)

Prolonged response on olaparib maintenance in metastatic pancreatic acinar cell carcinoma associated with a germline BRCA 2 mutation, revealed by severe panniculitis

New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations

Effect of Concomitant Proton Pump Inhibitors with Pazopanib on Cancer Patients: A Retrospective Analysis

Long-Term Use of Proton Pump Inhibitors in Cancer Patients: An Opinion Paper

Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients—First Results from the PAPESCO-19 Cohort Study

Transient Vision Loss – A Rare Oxaliplatin-Induced Ophthalmologic Side Effect: A Report of Two Cases

Retrorectal Mucinous Adenocarcinoma Arising from a Tailgut Cyst: A Case Report

Collaborators (3)

Aurélien Lambert

Tim Meyer

Come Lepage

Make your next move.